IP Library › Patent Application 10517882
Patent Application
App. No. 10/517,882

Formulation of nefopam and its use in the treatment of pain

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/517,882
Abstract

(+)-Nefopam is formulated for intranasal administration, for use in the treatment of pain.

Claims (4)

1 . (canceled)

2 . A composition comprising (+)-nefopam, suitable for intranasal administration.

3 . The composition, according to claim 2 , which comprises one or mucoadhesive agent, a solubility enhancer, a humectant, a buffer and water.

4 . A method for treating pain wherein said method comprises intransasal administration, to an individual in need of such treatment, of (+)-nefopam.

Assignments (2)
CHANGE OF NAME Recorded Jan 31, 2007
From: ARAKIS LIMITED
To: SOSEI R&D LTD.
Reel/Frame 018826/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2005
From: LYNE, MICHAEL
To: ARAKIS LTD
Reel/Frame 015520/0779 →